DIAGNOSIS, PROGNOSIS AND SCREENING FOR MEDICAMENTS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS USING RECEPTOR PROTEIN TYROSINE-PHOSPHATASE GAMMA (PTPRG) AS BIOMARKER - Patent 1987157

(19)

(11)

EP 1 987 157 A2

(12)

(88)	Date of publication A3:
	14.02.2008

(43)	Date of publication:
	05.11.2008 Bulletin 2008/45

(21)	Application number: 07700532.0

(22)	Date of filing: 22.01.2007

(51)

International Patent Classification (IPC):

C12Q 1/42^(2006.01)

G01N 33/574^(2006.01)

(86)	International application number:
	PCT/IB2007/000218

(87)	International publication number:
	WO 2007/085958 (02.08.2007 Gazette 2007/31)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

24.01.2006 IT VI20060029

(71)	Applicant: Consorzio Per Gli Studi Universitari In Verona
	37129 Verona (IT)

(72)	Inventor:
	SORIO, Claudio I-37124 Verona (IT)

(74)	Representative: Petraz, Gilberto Luigi et al
	GLP S.r.l. Piazzale Cavedalis 6/2 33100 Udine 33100 Udine (IT)

(54)	DIAGNOSIS, PROGNOSIS AND SCREENING FOR MEDICAMENTS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS USING RECEPTOR PROTEIN TYROSINE-PHOSPHATASE GAMMA (PTPRG) AS BIOMARKER